Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06158932 · ClinicalTrials.gov registry record · NA
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
A NA study of Polycystic Ovary Syndrome and Hormone Imbalance, sponsored by Optify.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06158932 is a NA study of Polycystic Ovary Syndrome and Hormone Imbalance that has completed, run by Optify. The registered enrollment target is 40 participants, below the 17,257-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06158932, a NA study of Polycystic Ovary Syndrome and Hormone Imbalance, has completed, sponsored by Optify.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a virtual single group study that will last 12 weeks. 40 female participants will take 4 capsules of the Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement per day. Questionnaires will be completed at Baseline, Week 4, Week 8 and Week 12. Participants will also provide a waist circumference measurement at Baseline and Week 12.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2024-01-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06158932
The ClinicalTrials.gov registry entry for NCT06158932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,257-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (100% lower). The listed sponsor is Optify, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement is the first listed.
NCT06158932 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06158932 about?
NCT06158932 is a clinical study titled "A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance". This is a virtual single group study that will last 12 weeks. 40 female participants will take 4 capsules of the Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement per day. Questionnaires will be completed at Baseline, Week 4, Week 8 and Week 12. Participants will also pro...
What is the current status of trial NCT06158932?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-08. Estimated completion is 2024-01-06.
What conditions does trial NCT06158932 study?
This clinical trial studies the following conditions: Polycystic Ovary Syndrome, Hormone Imbalance.
What interventions are being tested in trial NCT06158932?
The interventions under investigation include: Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06158932?
This trial is sponsored by Optify, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06158932 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Ovary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
IVM With Low Cost Priming, Enhanced Oocyte Recovery, and Delayed Transfer
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Myo-Inositol for Infertility in PCOS
RECRUITING · NA
-
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.